about
Epstein-barr virus sequence variation-biology and diseasePrimary Characterization of a Herpesvirus Agent Associated with Kaposi’s SarcomaA BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3AProtein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virusA nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain.Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus.A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenanceRNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection.The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genesInitiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined originMarked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.Immune regulation in Epstein-Barr virus-associated diseasesEpstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.Two related Epstein-Barr virus membrane proteins are encoded by separate genesEpstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMPEpstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.Characterization of EBV Promoters and Coding Regions by Sequencing PCR-Amplified DNA Fragments.Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation.Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes.Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity.Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds.The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virionsActivation domain requirements for disruption of Epstein-Barr virus latency by ZEBRA.The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines.Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells.Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr Virus lytic cycle progression.Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B.
P2860
Q27003183-80D965F0-B646-43CC-B52B-65E0798B1625Q27636336-E4458EEC-4455-41CC-A27E-683EE47356D6Q33632095-3D8CBDDF-DB7B-49FC-89C6-E5771980F851Q33760249-3BC70F61-5D04-42B3-BB6A-A3BD2F21D0BFQ33854424-DFC9E8EE-38FF-4CA4-B1F4-63E9EB766035Q33865166-7C8D46C3-0272-4AB7-9A84-94AA559A6125Q33937547-817C7DEE-78AA-4FC3-A417-59384AAE99F9Q33937673-003426E5-923E-492E-84A5-29D5636AFCA2Q33993543-BF76BE51-EB9F-484A-AFB2-A6D727576038Q34055287-242C7B13-C771-47DB-9132-A52A54053B5CQ34341875-EA9F8394-F0D7-448E-8A2D-BAB9143C4E70Q34583415-7DCF773D-88D2-468D-BCD0-32FF84CFF163Q35851440-2049C05E-13D5-4175-A31F-85E4399D3F49Q35852557-C72334BE-3928-4C14-88FA-ED941485EFD8Q36048272-467F818D-2E54-4A3D-A4A0-CA9B79E6C5CAQ36551194-FDB3F3B9-5D33-4A57-AA0B-39E49957F5CBQ36654123-55739E97-883C-45E6-9048-0C97B3E7C866Q36669953-FBF1A983-73E9-437D-8599-492A3038471CQ36688190-EEB3E8EA-FB5D-438D-A380-19B18BB9ECE6Q36780955-6D9E288A-F46F-4174-A002-DABE2953A9B1Q36782491-4DF8D3C9-6112-491A-A330-D761FA226640Q36801187-DCA17834-8A96-49F5-8F85-EB495FD61DC4Q36806063-D2027B22-DC2A-4A42-80E7-09E4D8D81E60Q36806077-67F7BAAE-19CA-4B4C-8961-6D668D07C68EQ38133428-6BBE129D-C3A8-4C37-BB4A-4D19CE57CDA6Q39165552-80DF1389-E09D-43A0-A238-CB6750B67DA9Q39296826-A04C4412-8D8B-4F30-87BE-958ADCA3713BQ39306073-73FC60B1-B078-4886-9F83-9EACFD1181A3Q39392105-D9B3B505-2456-4C4F-8BB8-F6E4B20C7426Q39593759-6DA6A318-14E5-47FC-A93F-8D639B530014Q39596888-5816DDB0-73C6-4439-BA95-7F8CB66ACC98Q39736781-332F425B-C7A7-4082-8C5C-1B9A286DB4D2Q39875400-24A5A69B-0562-4A56-9B4B-644F24E2CF48Q39877021-06447504-46EE-4BB0-8481-0BDC125893C6Q39880831-FA378091-9E8C-464B-92AE-BC2FB4FADAA0Q39883935-72BA2830-3DD0-46B9-858C-3F64C7EE0631Q40040836-27A38712-57F1-4398-8664-FCA18A934771Q40048036-D609BD07-CCF9-4DAD-A2E2-3AC2263B6523Q40069082-2788A253-252F-49D5-95E1-9E98D3CD18B3Q40100585-1493ABC1-8FDE-4E5A-8B08-0F8F54040E5F
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Sequence analysis of Raji Epstein-Barr virus DNA.
@en
Sequence analysis of Raji Epstein-Barr virus DNA.
@nl
type
label
Sequence analysis of Raji Epstein-Barr virus DNA.
@en
Sequence analysis of Raji Epstein-Barr virus DNA.
@nl
prefLabel
Sequence analysis of Raji Epstein-Barr virus DNA.
@en
Sequence analysis of Raji Epstein-Barr virus DNA.
@nl
P2093
P1433
P1476
Sequence analysis of Raji Epstein-Barr virus DNA.
@en
P2093
P304
P356
10.1016/0042-6822(88)90546-6
P407
P577
1988-06-01T00:00:00Z